TRUE Private Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,755
| Closed | -$215K | – | 223 |
|
|
2024
Q2 | $215K | Buy |
+2,755
| New | +$215K | 0.02% | 263 |
|
|
2024
Q1 | – | Sell |
-3,049
| Closed | -$205K | – | 287 |
|
|
2023
Q4 | $205K | Sell |
3,049
-570
| -16% | -$38.4K | 0.03% | 277 |
|
|
2023
Q3 | $245K | Buy |
+3,619
| New | +$245K | 0.03% | 222 |
|
|
2021
Q1 | – | Sell |
-1,700
| Closed | -$84K | – | 271 |
|
|
2020
Q4 | $84K | Hold |
1,700
| – | – | 0.01% | 293 |
|
|
2020
Q3 | $93K | Buy |
1,700
+100
| +6% | +$5.47K | 0.02% | 258 |
|
|
2020
Q2 | $84K | Hold |
1,600
| – | – | 0.02% | 258 |
|
|
2020
Q1 | $71K | Hold |
1,600
| – | – | 0.02% | 249 |
|
|
2019
Q4 | $79K | Buy |
+1,600
| New | +$79K | 0.01% | 320 |
|
|
2019
Q3 | – | Sell |
-5,880
| Closed | -$242K | – | 253 |
|
|
2019
Q2 | $242K | Sell |
5,880
-1,607
| -21% | -$66.1K | 0.04% | 175 |
|
|
2019
Q1 | $302K | Buy |
7,487
+1,468
| +24% | +$59.2K | 0.06% | 151 |
|
|
2018
Q4 | $228K | Buy |
6,019
+447
| +8% | +$16.9K | 0.04% | 208 |
|
|
2018
Q3 | $220K | Sell |
5,572
-1,834
| -25% | -$72.6K | 0.03% | 253 |
|
|
2018
Q2 | $260K | Buy |
+7,406
| New | +$260K | 0.04% | 229 |
|